Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;40(3):739-759.
doi: 10.1007/s10555-021-09980-4. Epub 2021 Aug 3.

Impact of posttranslational modifications in pancreatic carcinogenesis and treatments

Affiliations
Review

Impact of posttranslational modifications in pancreatic carcinogenesis and treatments

Nianhong Chen et al. Cancer Metastasis Rev. 2021 Sep.

Abstract

Pancreatic cancer (PC) is a highly aggressive cancer, with a 9% 5-year survival rate and a high risk of recurrence. In part, this is because PC is composed of heterogeneous subgroups with different biological and functional characteristics and personalized anticancer treatments are required. Posttranslational modifications (PTMs) play an important role in modifying protein functions/roles and are required for the maintenance of cell viability and biological processes; thus, their dysregulation can lead to disease. Different types of PTMs increase the functional diversity of the proteome, which subsequently influences most aspects of normal cell biology or pathogenesis. This review primarily focuses on ubiquitination, SUMOylation, and NEDDylation, as well as the current understanding of their roles and molecular mechanisms in pancreatic carcinogenesis. Additionally, we briefly summarize studies and clinical trials on PC treatments to advance our knowledge of drugs available to target the ubiquitination, SUMOylation, and NEDDylation PTM types. Further investigation of PTMs could be a critical field of study in relation to PC, as they have been implicated in the initiation and progression of many other types of cancer.

Keywords: NEDDylation; Pancreatic carcinogenesis; Posttranslational modification; SUMOylation; Treatments; Ubiquitination.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA A Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/10.3322/caac.21551 - DOI - PubMed
    1. Real, F. X. (2003). A “catastrophic hypothesis” for pancreas cancer progression. Gastroenterology, 124(7), 1958–1964. https://doi.org/10.1016/s0016-5085(03)00389-5 - DOI - PubMed
    1. Srivastava, S., Koay, E. J., Borowsky, A. D., De Marzo, A. M., Ghosh, S., Wagner, P. D., et al. (2019). Cancer overdiagnosis: A biological challenge and clinical dilemma. Nature Reviews Cancer, 19(6), 349–358. https://doi.org/10.1038/s41568-019-0142-8 - DOI - PubMed
    1. Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., et al. (2019). Cancer treatment and survivorship statistics, 2019. CA A Cancer Journal for Clinicians, 69(5), 363–385. https://doi.org/10.3322/caac.21565 - DOI - PubMed
    1. van Huijgevoort, N. C. M., Del Chiaro, M., Wolfgang, C. L., van Hooft, J. E., & Besselink, M. G. (2019). Diagnosis and management of pancreatic cystic neoplasms: Current evidence and guidelines. Nature Reviews. Gastroenterology & Hepatology, 16(11), 676–689. https://doi.org/10.1038/s41575-019-0195-x - DOI

Publication types

LinkOut - more resources